U.S. markets open in 5 hours 51 minutes

  • S&P Futures

    4,222.50
    +12.50 (+0.30%)
     

  • Dow Futures

    33,349.00
    +89.00 (+0.27%)
     

  • Nasdaq Futures

    13,459.25
    +67.25 (+0.50%)
     

  • Russell 2000 Futures

    1,975.60
    +6.10 (+0.31%)
     

  • Crude Oil

    91.83
    -0.10 (-0.11%)
     

  • Gold

    1,802.40
    -11.30 (-0.62%)
     

  • Silver

    20.50
    -0.25 (-1.19%)
     

  • EUR/USD

    1.0326
    +0.0024 (+0.24%)
     

  • 10-Yr Bond

    2.7860
    0.0000 (0.00%)
     

  • Vix

    19.84
    -1.93 (-8.87%)
     

  • GBP/USD

    1.2220
    +0.0001 (+0.01%)
     

  • USD/JPY

    132.5320
    -0.3410 (-0.26%)
     

  • BTC-USD

    24,657.20
    +1,682.13 (+7.32%)
     

  • CMC Crypto 200

    578.59
    +47.37 (+8.92%)
     

  • FTSE 100

    7,514.22
    +7.11 (+0.09%)
     

  • Nikkei 225

    27,819.33
    -180.63 (-0.65%)
     

Water trouble solutions on the horizon for Sanger residents

Residents of Sanger continue to struggle with ongoing water pressure problems. The city says relief is on the way.

Recommended Stories

  • ‘Load Up,’ Says Jim Cramer About These 2 ‘Strong Buy’ Stocks

    The last few years saw the markets go crazy. Between the COVID lockdowns and market crash, the rebound recovery, last year’s sustained bull run, and this year’s devastating first half that saw the bull turn into a bear. But in all of that, there have been stocks that have outperformed the market. These winning stocks have attracted attention from Jim Cramer, the well-known host of CNBC’s ‘Mad Money’ program. Among other things, Cramer has been following stocks which won big during the COVID cris

  • NIO: Mounting Headwinds Batter Investor Confidence

    Persistent supply issues have deflated expectations for the Chinese automaker

  • Fed to raise interest rates to 4% next year, Evans says

    (Reuters) -Wednesday's consumer price index report showing U.S. inflation didn't accelerate in July was the first "positive" reading on price pressures since the Federal Reserve began tightening policy, Chicago Fed President Charles Evans said, even as he signaled he believes the Fed has plenty more work to do. With consumer prices unchanged last month compared to June, but up 8.5% from a year earlier, inflation is still "unacceptably" high, and the Fed will likely need to lift its policy rate, currently in the 2.25%-2.5% range, to 3.25%-3.5% this year and to 3.75%-4% by the end of next year, Evans said. The remarks suggest Evans, among the 19 central bankers who set U.S. monetary policy, expects to soon slow what's been the Fed's steepest round of interest-rate hikes in decades.

  • Looking for Dividend Aristocrat Bargains? Here Are 2 Names That Analysts Like the Most

    Investors like getting a return on investment, of course, it’s why they are in the market to begin with. And when a company makes a commitment to return capital and profits to the shareholders, that’s a win – one that will both attract and reward investors. The key for investors is to find the best possible capital return, and dividend stocks make a logical place to start looking. With this in mind, we’ve used the TipRanks database to pull up the details on two true dividend aristocrats – real c

  • Down More Than 40%: These 2 ‘Strong Buy’ Stocks Are Flirting With a Bottom

    While every market advisor will tell you never to try to ‘time’ the market, timing is still important for success. Investors need to buy into low prices, and to do that, they need to know when prices are low. This doesn’t necessarily mean low in absolute dollar terms, but low relative to a stock’s recent past performance. In recognizing that lower price range, investors can turn to Wall Street’s pros for help. The analysts have been busy lately, picking out stocks that are in their lower price r

  • Market Surge After US Inflation Data Has Skeptics Warning It’s Overdone

    (Bloomberg) -- The cooler-than-expected US inflation reading for July is a positive sign that has buoyed risk assets, but some investors may be getting a little ahead of themselves, according to analysts.Most Read from BloombergMusk Sells Another $6.9 Billion of Tesla Ahead of Twitter TrialDozens in China Infected With New ‘Langya’ Virus Carried by ShrewsUS Inflation Runs Cooler Than Forecast, Easing Pressure on FedMedia Counts Differ With 10 Million Votes Counted: Kenya UpdateRussia Is Scouring

  • Social Security Benefits Are Projected to Increase. Here’s How Much.

    The Senior Citizens League projects the annual cost-of-living adjustment for 2023 to come in at 9.6%, down slightly from the prior month's estimate as inflation cooled a bit.

  • Meta’s Susan Li will join a growing group of Fortune 500 CFOs under 40

    The average age of a Fortune 500 CFO is 53, but a group of leaders became finance chiefs before their 40th birthday.

  • You'll Be Sorry If You Sell These 7 Value Stocks Now, Analysts Say

    Value stocks in the S&P 500 are outperforming this year. But analysts still think it's a mistake to part with some of them too soon.

  • Should I sell my house now before prices crash — or wait for the next big real estate boom?

    The housing market is changing fast. Act accordingly.

  • Rivian set to report second-quarter earnings after hours on Thursday

    Yahoo Finance Live co-host Rachelle Akuffo looks at Rivian's stock ahead of its earnings report due out tomorrow.

  • Coupang, Inc. (CPNG) Reports Q2 Loss, Misses Revenue Estimates

    Coupang, Inc. (CPNG) delivered earnings and revenue surprises of 63.64% and 2.24%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

  • Oregon biotech Siga Technologies set to deliver first monkeypox treatment

    Four years after Siga Technologies (Nasdaq: SIGA) gained approval for a smallpox drug, the Corvallis company is gearing up to get the same antiviral into a clinical trial for monkeypox. Tpoxx, also known as tecovirimat, is the only drug available to treat the virus, though it is not yet approved in the U.S. for the disease. The Food and Drug Administration designated Tpoxx as an investigational drug for monkeypox, allowing it to be released from the Strategic National Stockpile only after prescribers jump through considerable hoops.

  • Mocked by Everyone, Stock Rally Sits at Cusp of a Chart Landmark

    (Bloomberg) -- It’s doomed, it’s a bear-market rally, a rebound that won’t last. All the mud thrown at equities over the last month may well turn out to be true. But it’s getting harder to brush aside the recovery in the S&P 500 as it hovers at a widely watched landmark in charts.Most Read from BloombergMusk Sells Another $6.9 Billion of Tesla Ahead of Twitter TrialDozens in China Infected With New ‘Langya’ Virus Carried by ShrewsUS Inflation Runs Cooler Than Forecast, Easing Pressure on FedMedi

  • Dow Jones Pops On Inflation Data; Tesla Gains As Elon Musk Makes This Promise; Coinbase Up As Bitcoin Rallies

    The Dow Jones gained on inflation data. Tesla stock was up after Elon Musk made a promise. Coinbase was up amid a Bitcoin rally. Apple rose.

  • Plug stock powers up amid the latest green energy bill

    Yahoo Finance Live check out Plug's stock amid its earnings miss.

  • Are you still paying 1% to your financial adviser? Here’s what might make a lot more sense — and save you tens of thousands of dollars

    Many financial advisers charge based on how much money they manage on your behalf, and 1% of your total assets under management is a pretty standard fee. “Under $1 million dollars of investable assets, the flat fee may consume a very large percentage of their account and that would not be smart or advisable for the client,” says Paddock. In general, clients would do well to understand that percentage fees work well on smaller balances while flat fees are best for larger asset balances — and using the $1 million dollar threshold can be an easy way to draw a line in the sand for a client, says Kaleb Paddock, certified financial planner at Ten Talents Financial Planning.

  • What Awaits ZIM Integrated Shipping (ZIM) in Q2 Earnings?

    High fuel costs might have hurt the Q2 bottom-line performance of ZIM Integrated Shipping (ZIM).

  • Why semiconductor stocks should be avoided for now: Analyst

    Proceed with caution on chip stocks, warns one top analyst.

  • Dow Jones Futures Rise: Stock Market Rally Enters Power Trend; These 4 EV Plays Flash Buy Signals

    Stocks jumped on tame inflation, with the market rally now in a power trend. Lithium stocks flashed buy signals.